Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Talks

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Eye (London, England)|February 8, 2019
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumabS James Talks, Devangna Bhatia, Geeta Menon, et al.
The Journal of International Advanced Otology|January 31, 2023
Developing an Evidence-Based Surgical Curriculum: Learning from a Randomized Controlled Trial of Surgical Rehearsal in Virtual RealityBenjamin James Talks, Jesslyn Lamtara, Sudanthi Wijewickrema, et al.
JMIR Research Protocols|April 1, 2022
Stakeholder Perspectives on Clinical Decision Support Tools to Inform Clinical Artificial Intelligence Implementation: Protocol for a Framework Synthesis for Qualitative EvidenceMohaimen Al-Zubaidy, H D Jeffry Hogg, Gregory Maniatopoulos, et al.
Eye (London, England)|December 16, 2025
Development and standardisation of 'time-in-range' measurement for clinical endpoints in retinal diseasesLuisa Frizziero, Jane Barratt, Chui Ming Gemmy Cheung, et al.
Eye (London, England)|July 10, 2021
Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomesSobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, et al.
Eye (London, England)|March 21, 2023
Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomesSobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, et al.
Survey of Ophthalmology|February 25, 2019
The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degenerationJames Talks, Vincent Daien, Robert P Finger, et al.
Ophthalmology and Therapy|December 16, 2022
The Patient Voice in Neovascular Age-Related Macular Degeneration: Findings from a Qualitative StudyS James Talks, Vincent Daien, Paul Mitchell, et al.
Ophthalmology|August 9, 2020
Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic ReviewMali Okada, Paul Mitchell, Robert P Finger, et al.
Eye (London, England)|March 22, 2022
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practiceIan Pearce, Winfried Amoaku, Clare Bailey, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Eye (London, England)|February 8, 2019
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumabS James Talks, Devangna Bhatia, Geeta Menon, et al.
The Journal of International Advanced Otology|January 31, 2023
Developing an Evidence-Based Surgical Curriculum: Learning from a Randomized Controlled Trial of Surgical Rehearsal in Virtual RealityBenjamin James Talks, Jesslyn Lamtara, Sudanthi Wijewickrema, et al.
JMIR Research Protocols|April 1, 2022
Stakeholder Perspectives on Clinical Decision Support Tools to Inform Clinical Artificial Intelligence Implementation: Protocol for a Framework Synthesis for Qualitative EvidenceMohaimen Al-Zubaidy, H D Jeffry Hogg, Gregory Maniatopoulos, et al.
Eye (London, England)|December 16, 2025
Development and standardisation of 'time-in-range' measurement for clinical endpoints in retinal diseasesLuisa Frizziero, Jane Barratt, Chui Ming Gemmy Cheung, et al.
Eye (London, England)|July 10, 2021
Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomesSobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, et al.
Eye (London, England)|March 21, 2023
Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomesSobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, et al.
Survey of Ophthalmology|February 25, 2019
The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degenerationJames Talks, Vincent Daien, Robert P Finger, et al.
Ophthalmology and Therapy|December 16, 2022
The Patient Voice in Neovascular Age-Related Macular Degeneration: Findings from a Qualitative StudyS James Talks, Vincent Daien, Paul Mitchell, et al.
Ophthalmology|August 9, 2020
Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic ReviewMali Okada, Paul Mitchell, Robert P Finger, et al.
Eye (London, England)|March 22, 2022
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practiceIan Pearce, Winfried Amoaku, Clare Bailey, et al.
Pageof 7